NVO

Novo-Nordisk A/S
Data: 2026-03-30
$35.29
Price
-2.08%
Change
$81.44
52W High
$35.12
52W Low

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Quick Stats
Mar 30, 2026

53.0

AI Score

HOLD

0.75

Volume Ratio

May 06, 2026

Next Earnings

9

+ve Days (30d)

21

-ve Days (30d)

NVO Stock Summary

Last updated Mar 30, 2026

NVO is currently trading at $35.29, positioned below its 200-day moving average of $53.73, suggesting bearish momentum. The stock has a 52-week range of $35.12 to $81.44.

Technical Analysis: The 50-day moving average stands at $45.63, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.123, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.104, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NVO at 53.0/100 with a HOLD recommendation.

NVO (Novo-Nordisk A/S) Indicators

Last updated Mar 30, 2026

Indicator Value
RSI(14) 28.123
CMF (20) 0.104
ROC (10) -8.917
ADX (14) 36.824
Indicator Value
MACD (12,26,9) -2.305
AROONOSC (14) -64.286
WILLAMS %R (14) -99.518
MFI (14) 37.909
NVO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

NVO Price vs Max Options Open Interest
NVO Max Change In Options Open Interest

NVO Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVO Daily Out of Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVO Daily In the Money Options - Sort by Max open Interest (near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

NVO Most Active Options by Volume(near term)

30th March 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Novo-Nordisk A/S is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

NVO Moving Averages Analysis

NVO (Novo-Nordisk A/S) Simple Moving Averages

Moving Averages are last updated Mar 30, 2026

Days MA
10 36.73
20 37.6
30 39.19
50 45.63
100 47.98
200 53.73

NVO Fundamental Analysis

P/E (Forward) 10.8696
P/E (Trailing) 10.1676
Market Cap ($) 162.8 billion
Earnings/Share ($) 3.58
Net Proft Margin (%) 0.3314
Dividend/Share ($) 11.7
EPS Estimate Current Year ($) 21.3356
EPS Estimate Next Year ($) 21.9846
WallStreet Target Price ($) 46.9182
Most Recent Quarter